Unraveling the Role of Angiogenesis in Cancer Ecosystems

Activation of the tumor and stromal cell-driven angiogenic program is one of the first requirements in the tumor ecosystem for growth and dissemination. The understanding of the dynamic angiogenic tumor ecosystem has rapidly evolved over the last decades. Beginning with the canonical sprouting angiogenesis, followed by vasculogenesis and intussusception, and finishing with vasculogenic mimicry, the need for different neovascularization mechanisms is further explored. In addition, an overview of the orchestration of angiogenesis within the tumor ecosystem cellular and molecular components is provided. Clinical evidence has demonstrated the effectiveness of traditional vessel-directed antiangiogenics, stressing on the important role of angiogenesis in tumor establishment, dissemination, and growth. Particular focus is placed on the interaction between tumor cells and their surrounding ecosystem, which is now regarded as a promising target for the development of new antiangiogenics.

[1]  B. Lasseter Assays , 2019, Nature Biotechnology.

[2]  Janice A. Gasker Therapeutic Implications , 2019, “I Never Told Anyone This Before”.

[3]  Milad Shamsi,et al.  Translational models of tumor angiogenesis: A nexus of in silico and in vitro models. , 2018, Biotechnology advances.

[4]  Robert J. Griffin,et al.  Consensus guidelines for the use and interpretation of angiogenesis assays , 2018, Angiogenesis.

[5]  D. Noonan,et al.  Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy , 2018, Front. Immunol..

[6]  A. Zippelius,et al.  The multi-receptor inhibitor axitinib reverses tumor-induced immunosuppression and potentiates treatment with immune-modulatory antibodies in preclinical murine models , 2018, Cancer Immunology, Immunotherapy.

[7]  P. Hegde,et al.  Predictive markers of anti-VEGF and emerging role of angiogenesis inhibitors as immunotherapeutics. , 2017, Seminars in cancer biology.

[8]  Hellmut G. Augustin,et al.  Preclinical mouse solid tumour models: status quo, challenges and perspectives , 2017, Nature Reviews Cancer.

[9]  C. Bokemeyer,et al.  Mast cells decrease efficacy of anti-angiogenic therapy by secreting matrix-degrading granzyme B , 2017, Nature Communications.

[10]  T. Petrova,et al.  Microenvironmental regulation of tumour angiogenesis , 2017, Nature Reviews Cancer.

[11]  D. Ribatti,et al.  Mast cells in breast cancer angiogenesis. , 2017, Critical reviews in oncology/hematology.

[12]  Bruno Larrivée,et al.  Tumor angiogenesis and vascular normalization: alternative therapeutic targets , 2017, Angiogenesis.

[13]  D. Gabrilovich,et al.  Dendritic cells in cancer: the role revisited. , 2017, Current opinion in immunology.

[14]  K. Pantel,et al.  Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape , 2017, Nature Reviews Clinical Oncology.

[15]  Yiping Yang,et al.  Tumor-associated macrophages: implications in cancer immunotherapy. , 2017, Immunotherapy.

[16]  Ming Ding,et al.  Bone Formation by Sheep Stem Cells in an Ectopic Mouse Model: Comparison of Adipose and Bone Marrow Derived Cells and Identification of Donor-Derived Bone by Antibody Staining , 2016, Stem cells international.

[17]  Ignace Vergote,et al.  Final results of a phase 3 study of trebananib plus weekly paclitaxel in recurrent ovarian cancer (TRINOVA-1): Long-term survival, impact of ascites, and progression-free survival-2. , 2016, Gynecologic oncology.

[18]  Jennie W. Taylor,et al.  Abstract LB-347: Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival , 2016 .

[19]  W. ElShamy,et al.  Aggressiveness Niche: Can It Be the Foster Ground for Cancer Metastasis Precursors? , 2016, Stem cells international.

[20]  A. Azab,et al.  The role of hypoxia in cancer progression, angiogenesis, metastasis, and resistance to therapy , 2015, Hypoxia.

[21]  Bjorn Baselet,et al.  Metabolic changes associated with tumor metastasis, part 1: tumor pH, glycolysis and the pentose phosphate pathway , 2015, Cellular and Molecular Life Sciences.

[22]  Rakesh K. Jain,et al.  Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients , 2015, Proceedings of the National Academy of Sciences.

[23]  P. Carmeliet,et al.  Angiogenesis Revisited: An Overlooked Role of Endothelial Cell Metabolism in Vessel Sprouting , 2015, Microcirculation.

[24]  V. Rosti,et al.  Endothelial progenitor cells support tumour growth and metastatisation: implications for the resistance to anti-angiogenic therapy , 2015, Tumor Biology.

[25]  T. Maeda,et al.  Acidic extracellular pH promotes epithelial mesenchymal transition in Lewis lung carcinoma model , 2014, Cancer Cell International.

[26]  R. Jain Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. , 2014, Cancer cell.

[27]  D. Ribatti The chick embryo chorioallantoic membrane as a model for tumor biology. , 2014, Experimental cell research.

[28]  R. Jain,et al.  The role of mechanical forces in tumor growth and therapy. , 2014, Annual review of biomedical engineering.

[29]  F. Bianchini,et al.  Extracellular acidity, a “reappreciated” trait of tumor environment driving malignancy: perspectives in diagnosis and therapy , 2014, Cancer and Metastasis Reviews.

[30]  A. D. Van den Abbeele,et al.  Bevacizumab plus Ipilimumab in Patients with Metastatic Melanoma , 2014, Cancer Immunology Research.

[31]  B. Rini,et al.  Angiogenesis and the tumor microenvironment: vascular endothelial growth factor and beyond. , 2014, Seminars in oncology.

[32]  J. Brown,et al.  Vasculogenesis: a crucial player in the resistance of solid tumours to radiotherapy. , 2014, The British journal of radiology.

[33]  C. Fuchs,et al.  Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial , 2014, The Lancet.

[34]  D. Quail,et al.  Microenvironmental regulation of tumor progression and metastasis , 2013, Nature Medicine.

[35]  R. Jain,et al.  Vascular normalization as an emerging strategy to enhance cancer immunotherapy. , 2013, Cancer research.

[36]  Yongzhi Yang,et al.  HIFs, angiogenesis, and cancer , 2013, Journal of cellular biochemistry.

[37]  S. Sleijfer,et al.  Pazopanib, a new therapy for metastatic soft tissue sarcoma , 2013, Expert opinion on pharmacotherapy.

[38]  M. Mimeault,et al.  Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells , 2013, Journal of cellular and molecular medicine.

[39]  R. Watnick The role of the tumor microenvironment in regulating angiogenesis. , 2012, Cold Spring Harbor perspectives in medicine.

[40]  F. Otterbach,et al.  New Insight into the SDF-1/CXCR4 Axis in a Breast Carcinoma Model: Hypoxia-Induced Endothelial SDF-1 and Tumor Cell CXCR4 Are Required for Tumor Cell Intravasation , 2012, Molecular Cancer Research.

[41]  I. Geudens,et al.  Coordinating cell behaviour during blood vessel formation , 2011, Development.

[42]  J. Italiano,et al.  Release of angiogenesis regulatory proteins from platelet alpha granules: modulation of physiologic and pathologic angiogenesis. , 2011, Blood.

[43]  P. Carmeliet,et al.  Molecular mechanisms and clinical applications of angiogenesis , 2011, Nature.

[44]  D. Hanahan,et al.  Hallmarks of Cancer: The Next Generation , 2011, Cell.

[45]  R. Kelly,et al.  Target Inhibition in Antiangiogenic Therapy A Wide Spectrum of Selectivity and Specificity , 2010, Cancer journal.

[46]  Xin Lu,et al.  Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis , 2010, Clinical Cancer Research.

[47]  Min-Ying Su,et al.  Characterization of Pure Ductal Carcinoma In Situ on Dynamic Contrast-Enhanced MR Imaging: Do Nonhigh Grade and High Grade Show Different Imaging Features? , 2010, Journal of oncology.

[48]  Michael C. Schmid,et al.  Myeloid Cells in the Tumor Microenvironment: Modulation of Tumor Angiogenesis and Tumor Inflammation , 2010, Journal of oncology.

[49]  D. Ingber,et al.  Tumor growth and angiogenesis are dependent on the presence of immature dendritic cells , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  Hans-Peter Lipp,et al.  Tyrosine kinase inhibitors - a review on pharmacology, metabolism and side effects. , 2009, Current drug metabolism.

[51]  J. Knox,et al.  Sunitinib in solid tumors , 2009, Expert opinion on investigational drugs.

[52]  C. Betsholtz,et al.  Endothelial-mural cell signaling in vascular development and angiogenesis. , 2009, Arteriosclerosis, thrombosis, and vascular biology.

[53]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[54]  V. Bautch Endothelial Cells Form a Phalanx to Block Tumor Metastasis , 2009, Cell.

[55]  N. Ferrara,et al.  Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[56]  P. Comoglio,et al.  Tumor angiogenesis and progression are enhanced by Sema4D produced by tumor-associated macrophages , 2008, The Journal of experimental medicine.

[57]  R. Folberg,et al.  Demonstrating circulation in vasculogenic mimicry patterns of uveal melanoma by confocal indocyanine green angiography , 2008, Eye.

[58]  W. Gerald,et al.  TGFβ Primes Breast Tumors for Lung Metastasis Seeding through Angiopoietin-like 4 , 2008, Cell.

[59]  M. Koch,et al.  Tumor Escape from Endogenous, Extracellular Matrix–Associated Angiogenesis Inhibitors by Up-Regulation of Multiple Proangiogenic Factors , 2008, Clinical Cancer Research.

[60]  J. Folkman,et al.  Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.

[61]  Holger Gerhardt,et al.  Pericytes: gatekeepers in tumour cell metastasis? , 2008, Journal of Molecular Medicine.

[62]  D. Jin,et al.  Regulation of Vasculogenesis by Platelet-Mediated Recruitment of Bone Marrow–Derived Cells , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[63]  E. Sahai,et al.  Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells , 2007, Nature Cell Biology.

[64]  S. Robinson,et al.  The effects of tumor‐derived platelet‐derived growth factor on vascular morphology and function in vivo revealed by susceptibility MRI , 2007, International journal of cancer.

[65]  Michal Neeman,et al.  In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors. , 2007, Cancer research.

[66]  L. Ellis,et al.  Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. , 2007, The Journal of clinical investigation.

[67]  J. Boniver,et al.  [Ileum intussusception in an adult: a case report]. , 2007, Revue medicale de Liege.

[68]  D. McDonald,et al.  Mechanisms of adverse effects of anti-VEGF therapy for cancer , 2007, British Journal of Cancer.

[69]  Adam L. Bermange,et al.  Endothelial signalling by the Notch ligand Delta-like 4 restricts angiogenesis , 2007, Development.

[70]  S. Rafii,et al.  Thrombospondins deployed by thrombopoietic cells determine angiogenic switch and extent of revascularization. , 2006, The Journal of clinical investigation.

[71]  Wei Zhang,et al.  Vasculogenic mimicry is associated with high tumor grade, invasion and metastasis, and short survival in patients with hepatocellular carcinoma. , 2006, Oncology reports.

[72]  R. Motzer,et al.  Sunitinib in patients with metastatic renal cell carcinoma. , 2006, JAMA.

[73]  Holger Gerhardt,et al.  Pericytes limit tumor cell metastasis. , 2006, The Journal of clinical investigation.

[74]  Birgit Kasch,et al.  Next Generation , 2005, Im OP.

[75]  L. Chin,et al.  Epigenetic transdifferentiation of normal melanocytes by a metastatic melanoma microenvironment. , 2005, Cancer research.

[76]  M. Neeman,et al.  Functional and molecular mapping of uncoupling between vascular permeability and loss of vascular maturation in ovarian carcinoma xenografts: The role of stroma cells in tumor angiogenesis , 2005, International journal of cancer.

[77]  Peter Carmeliet,et al.  VEGF as a Key Mediator of Angiogenesis in Cancer , 2005, Oncology.

[78]  R. Rudolph,et al.  Artificial, non-antibody binding proteins for pharmaceutical and industrial applications. , 2005, Trends in biotechnology.

[79]  Z. Werb,et al.  PDGFRβ+ perivascular progenitor cells in tumours regulate pericyte differentiation and vascular survival , 2005, Nature Cell Biology.

[80]  Daniela S Krause,et al.  Tyrosine kinases as targets for cancer therapy. , 2005, The New England journal of medicine.

[81]  D. Ribatti,et al.  Microvascular density, vascular endothelial growth factor immunoreactivity in tumor cells, vessel diameter and intussusceptive microvascular growth in primary melanoma. , 2005, Oncology reports.

[82]  S. Itohara,et al.  Contribution of host MMP‐2 and MMP‐9 to promote tumor vascularization and invasion of malignant keratinocytes , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[83]  A. Ruddell,et al.  Myc regulates VEGF production in B cells by stimulating initiation of VEGF mRNA translation , 2005, Oncogene.

[84]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[85]  D. Gabrilovich Mechanisms and functional significance of tumour-induced dendritic-cell defects , 2004, Nature Reviews Immunology.

[86]  Ruslan Hlushchuk,et al.  Intussusceptive angiogenesis: Its emergence, its characteristics, and its significance , 2004, Developmental dynamics : an official publication of the American Association of Anatomists.

[87]  Peter Vaupel,et al.  The role of hypoxia-induced factors in tumor progression. , 2004, The oncologist.

[88]  S. Dimmeler,et al.  Endothelial progenitor cells functional characterization. , 2004, Trends in cardiovascular medicine.

[89]  Arjun Deb,et al.  Integrin Profile and In Vivo Homing of Human Smooth Muscle Progenitor Cells , 2004, Circulation.

[90]  Z. Werb,et al.  Regulation of matrix biology by matrix metalloproteinases. , 2004, Current opinion in cell biology.

[91]  A. Griffioen,et al.  Angiogenesis gene expression profiling in xenograft models to study cellular interactions. , 2004, Experimental cell research.

[92]  Masahiro Inoue,et al.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. , 2004, The Journal of clinical investigation.

[93]  Joe Tien,et al.  Mechanotransduction at cell-matrix and cell-cell contacts. , 2004, Annual review of biomedical engineering.

[94]  Stefan Walenta,et al.  Lactate: mirror and motor of tumor malignancy. , 2004, Seminars in radiation oncology.

[95]  R. Folberg,et al.  Vasculogenic mimicry , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[96]  J. Foidart,et al.  Membrane associated proteases and their inhibitors in tumour angiogenesis , 2004, Journal of Clinical Pathology.

[97]  T. Sjöblom,et al.  Platelet-derived growth factor production by B16 melanoma cells leads to increased pericyte abundance in tumors and an associated increase in tumor growth rate. , 2004, Cancer research.

[98]  M. Salgaller Technology evaluation: bevacizumab, Genentech/Roche. , 2003, Current opinion in molecular therapeutics.

[99]  C. Betsholtz,et al.  Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors. , 2003, The Journal of clinical investigation.

[100]  Tarik Tihan,et al.  The hypoxic response of tumors is dependent on their microenvironment. , 2003, Cancer cell.

[101]  Seth M Steinberg,et al.  A randomized trial of bevacizumab, an anti-vascular endothelial growth factor antibody, for metastatic renal cancer. , 2003, The New England journal of medicine.

[102]  M. Seiki,et al.  Roles of pericellular proteolysis by membrane type‐1 matrix metalloproteinase in cancer invasion and angiogenesis , 2003, Cancer science.

[103]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[104]  M. Hendrix,et al.  Angiogenesis: Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma , 2003, Nature Reviews Cancer.

[105]  R. Kalluri Basement membranes: structure, assembly and role in tumour angiogenesis , 2003, Nature reviews. Cancer.

[106]  Rakesh K Jain,et al.  Molecular regulation of vessel maturation , 2003, Nature Medicine.

[107]  O. Volpert,et al.  Wiring the angiogenic switch: Ras, Myc, and Thrombospondin-1. , 2003, Cancer cell.

[108]  J. Folkman,et al.  Clinical translation of angiogenesis inhibitors , 2002, Nature Reviews Cancer.

[109]  S. Rafii,et al.  Recruitment of Stem and Progenitor Cells from the Bone Marrow Niche Requires MMP-9 Mediated Release of Kit-Ligand , 2002, Cell.

[110]  A. Harris,et al.  Tumor-Associated Macrophages in Breast Cancer , 2002, Journal of Mammary Gland Biology and Neoplasia.

[111]  Rakesh K Jain,et al.  Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. , 2002, The American journal of pathology.

[112]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[113]  S. Rafii,et al.  The Id proteins and angiogenesis , 2001, Oncogene.

[114]  Mina J. Bissell,et al.  Putting tumours in context , 2001, Nature Reviews Cancer.

[115]  J. Abbruzzese,et al.  Regulation of vascular endothelial growth factor expression by acidosis in human cancer cells , 2001, Oncogene.

[116]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[117]  M J Bissell,et al.  Tumors are unique organs defined by abnormal signaling and context. , 2001, Seminars in cancer biology.

[118]  Peter C. Brooks,et al.  New Functions for Non-collagenous Domains of Human Collagen Type IV , 2000, The Journal of Biological Chemistry.

[119]  P. Meltzer,et al.  Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. , 1999, The American journal of pathology.

[120]  N. Ferrara Role of vascular endothelial growth factor in the regulation of angiogenesis. , 1999, Kidney international.

[121]  T. Shono,et al.  Macrophage infiltration and heme oxygenase-1 expression correlate with angiogenesis in human gliomas. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[122]  R. Xavier,et al.  Tumor Induction of VEGF Promoter Activity in Stromal Cells , 1998, Cell.

[123]  H. Kroemer,et al.  Elucidation of the mechanism enabling tumor selective prodrug monotherapy. , 1998, Cancer research.

[124]  L. Matrisian,et al.  Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.

[125]  Harold E. Dvorak,et al.  Angiogenesis: a Dynamic Balance of Stimulators and Inhibitors , 1997, Thrombosis and Haemostasis.

[126]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[127]  D. Hanahan,et al.  Patterns and Emerging Mechanisms of the Angiogenic Switch during Tumorigenesis , 1996, Cell.

[128]  R. Hildenbrand,et al.  Urokinase and macrophages in tumour angiogenesis. , 1995, British Journal of Cancer.

[129]  R. Kerbel,et al.  Consequences of angiogenesis for tumor progression, metastasis and cancer therapy. , 1995, Anti-cancer drugs.

[130]  Cord Sunderkötter,et al.  Macrophages and angiogenesis , 1994, Journal of leukocyte biology.

[131]  J. Folkman What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[132]  P H Burri,et al.  Scanning electron microscope study of the developing microvasculature in the postnatal rat lung , 1986, The Anatomical record.

[133]  J. Folkman,et al.  Mast cells and tumor angiogenesis , 1976, International journal of cancer.

[134]  R. G. Berry,et al.  Chorioallantoic membrane heterotransplantation of human brain tumors , 1975, International journal of cancer.

[135]  J. Folkman Tumor angiogenesis: therapeutic implications. , 1971, The New England journal of medicine.

[136]  F. Becker,et al.  Growth and metastasis of tumor in organ culture , 1963, Cancer.

[137]  H. W. Chalkley,et al.  Vascular reactions of normal and malignant tissues in vivo. III. Vascular reactions' of mice to fibroblasts treated in vitro with methylcholanthrene. , 1950, Journal of the National Cancer Institute.

[138]  O. Warburg,et al.  THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.

[139]  Michael Schwenk,et al.  Tumor , 1828, The London medical and physical journal.

[140]  H. Spaink,et al.  Imaging Cancer Angiogenesis and Metastasis in a Zebrafish Embryo Model. , 2016, Advances in experimental medicine and biology.

[141]  Izhak Haviv,et al.  Co-evolution of tumor cells and their microenvironment. , 2009, Trends in genetics : TIG.

[142]  A. Peled,et al.  CXCR4 antagonists: targeting the microenvironment in leukemia and other cancers , 2009, Leukemia.

[143]  F. Orsenigo,et al.  Organization and signaling of endothelial cell-to-cell junctions in various regions of the blood and lymphatic vascular trees , 2008, Cell and Tissue Research.

[144]  Valentin Djonov,et al.  New insights into intussusceptive angiogenesis. , 2005, EXS.

[145]  C. Turner,et al.  JCB Article , 2001 .

[146]  E. Hirsch,et al.  Tissue-specific KO of ECM proteins. , 2000, Methods in molecular biology.

[147]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[148]  D. C. Henckel,et al.  Case report. , 1995, Journal.

[149]  S. Paku,et al.  First steps of tumor-related angiogenesis. , 1991, Laboratory investigation; a journal of technical methods and pathology.